Background and objective Renal hypertension is very frequent in secondary hypertension.
背景和目的肾实质性高血压是最常见的继发性高血压。
High blood pressure can be divided into primary hypertension and secondary hypertension.
分为原发性高血压和继发性高血压。
This "secondary hypertension" small, high blood pressure about the total number of about 5%.
这种“继发性高血压”很少，约占高血压总数的5%左右。
Results: 1 of 4514 in-patients with hypertension, there were 83.81% of essential hypertension and 17.94% of secondary hypertension.
结果：14514例高血压住院患者中原发性高血压的检出率为83.81%，继发性高血压的检出率为17.94%。
Secondary hypertension comprised 51.3% of endocrine hypertension, 24.8% of renovascular hypertension (RVH)and 22.3% of renal hypertension.
在继发性高血压中，内分泌性高血压占51·3%，肾血管性高血压占24·8%； 肾性高血压占22·3%。
We selected RCTs studying patients with primary hypertension. We excluded studies of patients with secondary hypertension or gestational hypertension.
我们选择随机分配对照试验，研究原发性高血压病人，排除了次发性高血压或妊娠性高血压的病人。
Pheochromocytoma is an important cause of secondary hypertension, whose pathogenesis is yet to be clarified. It is still difficult to identify malignant cases at early stage.
嗜铬细胞瘤是引起继发性高血压的重要原因，其发病机制目前还不完全清楚，临床上早期鉴别良恶性肿瘤尚有困难。
Secondary hypertension is caused by a preexisting medical condition such as congestive heart failure, kidney failure, liver failure, or damage to the endocrine (hormone) system.
继发性高血压是由疾病引起的，如充血性心力衰竭、肾衰、肝衰或内分泌(激素)系统受损。
Conclusion Edaravone is safe and effective in the treatment of brain damage secondary to hypertension intracerebral hemorrhage.
结论依达拉奉对高血压脑出血继发性脑损伤的治疗是安全有效的。
Conclusion (1) The general practice team services could control hypertension in community effectively, which is a new intervention pattern for the secondary prevention of hypertension.
结论（1）全科团队服务模式能够有效地控制社区原发性高血压，是进行高血压二级预防的新型社区干预模式；
Objective To study the diagnosis and treatment of portal hypertension in secondary biliary cirrhosis(PHSBC).
目的探讨继发性胆汁性肝硬变门脉高压症的诊断和治疗。
While the arrhythmia and hypertension secondary to SRBD may aggravate VBI.
SRBD继发的心律改变和高血压可加重VBI。
Serum uric acid (SUA) was measured in 63 patients with essential hypertension, secondary hyperuricemia excluded, and in 68 controls with normal blood pressure.
对排除了继发性高尿酸血症的原发性高血压患者63例及正常血压68人测定其血尿酸水平。
Conclusion Combined use of PGE1 with conventional therapy has much stronger efficacy in the treatment of secondary pulmonary hypertension.
结论在常规治疗的基础上联合使用PGE1可以明显降低继发性肺动脉高压。
Objective: to investigate the surgical treatment of 15 patients with portal hypertension of secondary biliary cirrhosis due to hepatolithiasis (PHSBCH).
目的：探讨15例因肝胆管结石至胆管狭窄合并胆汁性肝硬变门脉高压症(PHSBCH)的外科治疗。
Objectives to analyze the clinical characteristics and prognosis of pulmonary hypertension secondary to rheumatic diseases.
目的探讨风湿性疾病继发肺动脉高压的临床特点及预后相关因素。
Help to discover hypertension in early phase, identify primary, secondary and other hypertension.
帮助早期发现高血压，鉴别原发、继发及其他类型高血压症。
There were more patients complicated with hypertension and secondary polycythemia inOSAS group than in control group.
OSAS组的高血压和继发性红细胞增多症明显高于对照组。
Objective to discuss the diagnosis and treatment of portal hypertension secondary to myeloproliferative diseases.
目的探讨骨髓增生性疾病致门静脉高压症的诊断及治疗。
Hemodynamic changes in 90 patients with pulmonary hypertension secondary to chronic cor pulmo-nale were reported.
对肺心病90例患者进行血流动力学观察。
Pulmonary hypertension is divided into primary pulmonary hypertension and secondary pulmonary hypertension.
肺动脉高压分为原发性和继发性肺动脉高压。
In patients with portosystemic shunting secondary to portal hypertension, hepatic arterial flow often increases to compensate for reduced portal flow (139, 178) (Fig. 6.4).
因为门脉高压出现门体分流的病人，肝动脉的血流量常常有所增加以补偿减少了的门脉血流(139,178)(如图6.4)。
In patients with portosystemic shunting secondary to portal hypertension, hepatic arterial flow often increases to compensate for reduced portal flow (139, 178) (Fig. 6.4).
因为门脉高压出现门体分流的病人，肝动脉的血流量常常有所增加以补偿减少了的门脉血流(139,178)(如图6.4)。
应用推荐